BF Biosciences Limited - BFBIO

Rs 154.26

Change 2.26

On Oct 31

Trades end of day

Last trade on Oct 31, 2025 Day's range Rs 152.00 - 157.89
Change Rs 2.26 52 week range Rs 91.00 - 253.97
Open Rs 152.00 Volume 439,886
Close Rs 154.26 Previous Close Rs 154.26

BFBIO Company Meetings

No Meetings
 

BFBIO Trade Activity

Period High Low Volume
1M 163.52 148.65 14,464,844.00; Avg 688,802.10
3M 185.17 148.65 46,961,250.00; Avg 733,769.53
6M 188.66 122.42 117,448,593.00; Avg 932,131.69
1Y 243.36 91.33 344,376,930.00; Avg 1,383,039.88
 
 

Latest Annual Financials

Financial Year O/S Shares 0.00m
Net Profit Rs 0.00m Market Cap Rs 0.00m
EPS 0.00 P/E 0.00
Par Value Rs 0.00 Book Value 0.00
Net Worth Rs 0.00m Outstanding Shares 0.00m
Dividend Rs 0.00 ROE 0.00%
Dividend Yield 0.00% Divident Payout 0.00%
Earnings Yield 0.00% Sharia No
 

Price Chart

Yasir Mahmood Securities has partnered with TradingView for its charting solution.
A comprehensive trading platform which offers intuitive analytical tools, stock screener and real time economic calendar data to track key financial events.

 

The company is in the Pharmaceuticals sector.

 

Other Companies in This Sector

Company Current Change Date
Abbot Laboratories Rs 1,119.78 1.80% Oct 31, 2025
AGP Limited Rs 193.53 0.73% Oct 31, 2025
BF Biosciences Limited Rs 154.26 1.49% Oct 31, 2025
Citi Pharma Limited Rs 83.76 0.92% Oct 31, 2025
Ferozsons Laboratories Limited Rs 400.23 0.33% Oct 31, 2025
Glaxosmithkline Rs 398.72 -0.32% Oct 31, 2025
Glaxo Healthcare Pakistan Rs 120.23 -3.20% Jan 30, 2023
Haleon Pakistan Limited Rs 854.02 -0.46% Oct 31, 2025
Highnoon Laboratories Rs 1,136.03 -1.21% Oct 31, 2025
Hoechst Pakistan Limited Rs 4,235.00 1.43% Oct 31, 2025
IBL Healthcare Limited Rs 46.71 0.52% Oct 31, 2025
IBL Healthcare Limited (r) Rs 0.00 0.00% Nov 02, 2025
Liven Pharma Limited Rs 57.58 -2.36% Oct 31, 2025
Macter International Limited Rs 346.91 2.03% Oct 31, 2025
Macter International Limited (r) Rs 0.00 0.00% Nov 02, 2025
 

Shareholding Pattern

Year Individual Institutions Investment Companies Foreign Investors Government Shareholders Other